1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Formulation development of a recombinant VAR2-antiCD3 protein for cancer immunotherapy
(
- Master (Two yrs)
- 2018
-
Mark
Stock Performance Differences in Swedish Life Science Companies with or without Research-based Science Park Affiliation
(
- Master (One yr)
- 2017
-
Mark
Från hamnar till hälsa - en studie av life science kluster i Kobe och Göteborg
(
- Bach. Degree